337903 <common-name>N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide</common-name> <description>N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide is a chemical compound with the formula C24H18BrClFN5OS. With an average molecular weight of 558.90 g/mol, N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide is a heavy molecule.</description> <cas>303105-41-1</cas> <pubchem-id>6868948</pubchem-id> <chemical-formula>C24H18BrClFN5OS</chemical-formula> <weight>558.9</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-30T20:53:00Z</created-at> <updated-at type="dateTime">2026-08-30T20:53:00Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NN=CC3=C(C=CC(=C3)Br)F)C4=CC=C(C=C4)Cl</moldb-smiles> <moldb-formula>C24H18BrClFN5OS</moldb-formula> <moldb-inchi>InChI=1S/C24H18BrClFN5OS/c1-15-2-9-20(10-3-15)32-23(16-4-7-19(26)8-5-16)30-31-24(32)34-14-22(33)29-28-13-17-12-18(25)6-11-21(17)27/h2-13H,14H2,1H3,(H,29,33)/b28-13+</moldb-inchi> <moldb-inchikey>APQZUHBGQZOYHF-XODNFHPESA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">557.0088</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>6.4</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM333796</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[(e)-(5-bromo-2-fluorophenyl)methylideneamino]-2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0288332</sync-id> <structure-inchikey>APQZUHBGQZOYHF-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800000000800000000000000000000400080005000000000000000000002000004008000002080000000000000000000000000200000000000000000400000000000000000000020400000000210000004800010000200000000010080000000000080100000800400080100000040000000000000000000000040020000000000000000000084880800010000000000000000000000000000000000000000000000080000000000000000400000000000002c00000000000000004000000000000100000000000010000000002000000200000000000000000140008000001048000000000480800000810000000040000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJQAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB B0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBBAAIAAA AAIGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEHACgAAAADAwYA aAAAAAMDAQZAKAAAAAMEBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgA AAADBAZAaAAAAAMDASMAIAAAAAEJACAAAAABBkAoAAAAAwQGQGgAAAADAwEG QGgAAAADAwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAREAIAAAAAELAAEA AQJoDAIDaAwDBGgMBAVoDAUGaAwEByAHCGgMCAloDAkKaAwKC2gMCwwADA0A DQ4ADg8oAg4QIBARIBESKAISEyATFGgMFBVoDBUWaAwWF2gMFxhoDBcZABQa AAgbIBscaAwcHWgMHR5oDB4faAwfIGgMHiEABgFoDAsHaAwYE2gMIBtoDEIE AAAABgEGBQQDAgUJCAcLCgYUFRYXGBMGHB0eHyAbFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:38:50Z</structure-indexed-at> </compound>